In the BioHarmony Drug Report Database

"Preview" Icon

Bezlotoxumab

Zinplava (bezlotoxumab) is an antibody pharmaceutical. Bezlotoxumab was first approved as Zinplava on 2016-10-21. It is used to treat clostridium infections in the USA. It has been approved in Europe to treat pseudomembranous enterocolitis.

 

Trade Name

 

Zinplava
 

Common Name

 

bezlotoxumab
 

ChEMBL ID

 

CHEMBL2108670
 

Indication

 

clostridium infections, pseudomembranous enterocolitis
 

Drug Class

 

Monoclonal antibodies

Image (chem structure or protein)

Bezlotoxumab structure rendering